Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension

Journal of Neurochemistry

Volumn 110, Issue 6, 2009, Pages 1908-1920

  Krabbe, Christina ^a,b   Courtois, Elise ^c   Jensen, Pia ^a   Jørgensen, Jesper R ^b   Zimmer, Jens ^a   Martínez Serrano, Alberto ^c   Meyer, Morten ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NsGene AS   (Denmark)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Dopamine; Parkinson's disease; Precursor cells; Tyrosine hydroxylase; Ventral mesencephalon

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DOPAMINE; FIBROBLAST GROWTH FACTOR 8; FORSKOLIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROTEIN BCL XL; SONIC HEDGEHOG PROTEIN; TYROSINE 3 MONOOXYGENASE;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; MESENCEPHALON; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; OXYGEN TENSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS INDUCING FACTOR; BCL-X PROTEIN; BROMODEOXYURIDINE; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIBUTYRYL CYCLIC GMP; DOPAMINE; EMBRYONIC STEM CELLS; FETUS; FORSKOLIN; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HN PROTEIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IONOPHORES; L-LACTATE DEHYDROGENASE; MESENCEPHALON; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; OXYGEN; PHORBOL ESTERS; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

ERINACEIDAE;

EID: 69949154151     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06281.x     Document Type: Article

References (39)

1. Akcali K. C., Sahiner M. Sahiner T. (2005) The role of bcl-2 family of genes during kindling. Epilepsia 46, 217 223.
2. Anwar M. R., Andreasen C. M., Lippert S. K., Zimmer J., Martinez-Serrano A. Meyer M. (2008) Dopaminergic differentiation of human neural stem cells mediated by cocultured rat striatal brain slices. J. Neurochem. 105, 460 470.
3. Asanuma M., Miyazaki I., diaz-Corrales F. J. Ogawa N. (2004) Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism. Acta Med. Okayama 58, 221 233 (Review).
4. Barazzone C. White C. W. (2000) Mechanisms of cell injury and death in hyperoxia. Role of cytokines and Bcl-2 family proteins. Amer. J. Resp. Cell. Mol. Biol. 22, 1246 1255.
5. Björklund A., Dunnett S. B., Brundin P., Stoessl A. J., Freed C. R., Breeze R. E., Levivier M., Peschanski M., Studer L. Barker R. (2003) Neural transplantation for the treatment of Parkinson's disease. The Lancet Neurol. 2, 437 445.
6. Blömer U., Kafri T., Randolph-Moore L., Verma I. M. Gage F. H. (1998) Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proc. Natl. Acad. Sci. 95, 2603 2608.
7. Brundin P., Karlsson J., Emgard M., Schierle G. S., Hansson O., Petersen A. Castilho R. F. (2000a) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 9, 179 195. (Pubitemid 30252685)
8. Brundin P., Pogarell O., Hagell P. et al. (2000b) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123, 1380 1390.
9. Bucellato L. J., Tso M., Akinci O. I., Chandel N. S. Budinger G. R. (2004) Reactive oxygen species are required for hyperoxia-induced bax activation and cell death in alveolar epithelial cells. J. Biol. Chem. 279, 6753 6760.
10. Castedo M., Ferri K., Roumier T., Métivier D., Zamzami N. Kroemer G. (2002) Quantification of mitochondiral alterations associated with apoptosis. J. Immunol. Methods 265, 39 47.
11. Chandel N. S. Budinger G:. R. (2007) The cellular basis for diverse responses to oxygen. Free Radic. Biol. Med. 42, 165 174.
12. Dauer W. Przedborski S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 899 909.
13. Dietz G. P., Stockhausen K. V., Dietz B. et al. (2008) Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra. J. Neurochem. 104, 757 765.
14. Freed C. R., Breeze R. E., Rosenberg N. L., Schneck S. A., Wells T. H., Barrett J. N., Gratton S. T., Mazziotta J. C., Eidelberg D. Rottenberg D. A. (1990) Therapeutic effects of human fetal dopaminergic cells transplanted in a patient with Parkinson's disease. Prog. Brain Res. 82, 715 721.
15. Freed C. R., Greene P. E., Breeze R. E. et al. (2001) Transplantation of embryonic dopaminergic neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710 719.
16. Hartmann A., Mouatt-Prigent A., Vila M., Abbas N., Perier C., Faucheux B. A., Vyas S. Hirsch E. C. (2002) Increased expression and redistribution of the antiapoptotic molecule Bcl-XL in Parkinson's disease. Neurobiol. Dis. 10, 28 32.
17. Jensen P., Bauer M., Jensen C. H., Widmer H. R., Gramsbergen J. B., Blaabjerg M., Zimmer J. Meyer M. (2007) Expansion and characterization of ventral mesencephalic precursor cells: Influence of mitogens and investigation of FA1 as a potential dopaminergic marker. J. Neuroscience Res. 85, 1884 1893.
18. Jørgensen J. R., Juliusson B., Henriksen K. F., Hansen C., Knudsen S., Petersen T. N., Blom N., Seiger A. Wahlberg L. U. (2006) Identification of novel genes regulated in the developing human ventral mesencephalon. Exp. Neurol. 198, 427 437.
19. Krajewska M., Mai J. K., Zapata J. M., Ashwell K. W. S., Schendel S. L., Reed J. C. Krajewski S. (2002) Dynamics of expression of apoptosis-regulatory proteins Bid, Bcl-2, Bcl-X, Bax and Bak during development of murine nervous system. Cell Death Diff. 9, 145 157.
20. Lindvall O. Björklund A. (2004) Cell therapy in Parkinson's disease. NeuroRx 1, 382 393.
21. L, both in vitro and in vivo. J. Neurosci. 24, 10786 10795.
22. Liste I., Garcia-Garcia E., Bueno C. Martínez-Serrano A. (2007) Bcl-XL modulates the differentiation of immortalized human neural stem cells. Cell Death Differ. 14, 1880 1892.
23. Lotharius J. Brundin P. (2002) Pathogenesis of Parkinson's disease: Dopamine, vesicles, and a α-synuclein. Nat. Rev. 3, 1 11 (Review).
24. Maciaczyk J., Singec I., Maciaczyk D. Nikkhah G. (2008) Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells. Exp. Neurol. 213, 354 362.
25. McClintock D. S., Santore M. T., Lee V. Y., Brunelle J., Budinger S. G. R., Zong W. X., Thompson C. B., Hay N. Chandel N. S. (2002) Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol. Cell. Biol. 22, 94 104.
26. Meyer M., Johansen J., Gramsbergen J. B., Johansen T. E. Zimmer J. (2000) Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line. Exp. Neurol. 164, 82 93.
27. Meyer M., Matarredona E. R., Seiler R. W., Zimmer J. Widmer H. R. (2001) Additive effect of glial cell line-derived neurotrophic factor and neurotrophin-4/5 on rat fetal nigral explant cultures. Neuroscience 108, 273 284.
28. Milosevic J., Schwarz S. C., Krohn K., Poppe M., Storch A. Schwarz J. (2005) Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors. J. Neurochem. 92, 718 729.
29. Morrison S. J., Csete M., Grover A. K., Melega W., Wold B. Anderson D. J. (2000) Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J. Neurosci. 20, 7370 7376.
30. Neuhaber J. A. Sunderram J. (2004) Oxygen-sensing neurons in the central nervous system. J. App. Physiol. 96, 367 374.
31. Offen D., Beart P. M., Cheung N. S., Pascoe C. J., Hochman A., Gorodin S., Melamed E., Bernard R. Bernard O. (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc. Natl Acad. Sci. USA 95, 5789 5794.
32. Rolletschek A., Chang H., Guan K., Czyz J., Meyer M. Wobus A. M. (2001) Differentiation of embryonic stem cell-derived dopaminergic neurons is enhanced by survival-promoting factors. Mech. Dev. 105, 93 104.
33. Savitt J. M., Jang S. S., Mu W., Dawson V. L. Dawson T. M. (2005) Bcl-x is required for proper development of the mouse substantia nigra. J. Neurosci. 25, 6721 6728.
34. Shim J. W., Koh H. C., Chang M. Y., Roh E., Choi C. Y., Oh Y. J., Son H., Lee Y. S., Studer L. Lee S. H. (2004) Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells over-expressing Bcl-xL. J. Neurosci. 24, 843 852.
35. Silver I. Erecinska M. (1998) Oxygen and ion concentrations in normoxic and hypoxic brain cells. Adv. Exp. Med. Biol. 454, 7 16.
36. Storch A., Paul G., Csete M., Boehm B. O., Carvey P. M., Kupsch A. Schwarz J. (2001) Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp. Neurol. 170, 317 325.
37. Studer L., Csete M., Lee S. H., Kabbani N., Walikonis J., Wold B. McKay R. (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors at lowered oxygen. J. Neurosci. 20, 7377 7383.
38. Trollmann R. Gassmann M. (2009) The role of hypoxia-inducible transcription factors in the hypoxic neonatal brain. Brain Dev. 31, 503 509.
39. Villa A., Liste I., Courtois E. T., Seiz E. G., Ramos M., Meyer M., Juliusson B., Kusk P. Martínez-Serrano A. (2009) Generation and properties of a new human ventral mesencephalic neural stem cell line. Exp. Cell Res. 315, 1860 1874.